We partnered with the British High Commission (BHC) on a UK-India policy exchange between experts on regulatory approaches to AI/ ML enabled health-tech. The essence of our recommendations were also featured in the speech of the then UK Prime Minister Boris Johnson when he visited India in April 2022. As part of the project, we built a well-balanced cohort of Indian experts comprising of senior government officials, start-ups, academia, and industry leaders, who visited the UK to exchange ideas with UK experts. We also leveraged our understanding of global privacy laws to bring out similarities and differences between the two regions and to identify themes that would be most valuable to India. On the back of this research, we organised a 5-day study tour which involved sessions with the NHS UK, NHS AI Lab, the Medicines and Health Products Regulatory Agency, and incubation centres researching AI/ML tools. The Indian cohort took back lessons on privacy, including methods such as differential privacy and the use of synthetic data in trials and for testing validity, and checklists/ assessments that developers must fill before accessing training data for AI/ML models. The project culminated in a learnings paper that documents takeaways from UK approaches and a report that sets out ideas for future India-UK projects.